Synthesis and pharmacology of 3-hydroxy-delta2-isoxazoline-cyclopentane analogues of glutamic acid
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Synthesis and pharmacology of 3-hydroxy-delta2-isoxazoline-cyclopentane analogues of glutamic acid. / Conti, P; De Amici, M; Bräuner-Osborne, Hans; Madsen, U; Toma, L; De Micheli, C.
In: Farmaco, Vol. 57, No. 11, 11.2002, p. 889-95.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Synthesis and pharmacology of 3-hydroxy-delta2-isoxazoline-cyclopentane analogues of glutamic acid
AU - Conti, P
AU - De Amici, M
AU - Bräuner-Osborne, Hans
AU - Madsen, U
AU - Toma, L
AU - De Micheli, C
PY - 2002/11
Y1 - 2002/11
N2 - The synthesis and pharmacology of two potential glutamic acid receptor ligands are described. Preparation of the bicyclic 3-hydroxy-delta2-isoxazoline-cyclopentane derivatives (+/-)-7 and (+/-)-8 was accomplished via 1,3-dipolar cycloaddition of bromonitrile oxide to suitably protected 1-amino-cyclopent-3-enecarboxylic acids. Their structure was established using a combination of 1H NMR spectroscopy and molecular mechanics calculations carried out on the intermediate cycloadducts (+/-)-11 and (+/-)-12. Amino acid derivatives (+/-)-7 and (+/-)-8 were assayed at ionotropic and metabotropic glutamic acid receptor subtypes and their activity compared with that of trans-ACPD and cis-ACPD. The results show that the replacement of the omega-carboxylic group of the model compounds with the 3-hydroxy-delta2-isoxazoline moiety abolishes or reduces drastically the activity at the metabotropic glutamate receptors. Conversely, on passing from cis-ACPD to derivative (+/-)-8, the agonist activity at NMDA receptors is almost unaffected.
AB - The synthesis and pharmacology of two potential glutamic acid receptor ligands are described. Preparation of the bicyclic 3-hydroxy-delta2-isoxazoline-cyclopentane derivatives (+/-)-7 and (+/-)-8 was accomplished via 1,3-dipolar cycloaddition of bromonitrile oxide to suitably protected 1-amino-cyclopent-3-enecarboxylic acids. Their structure was established using a combination of 1H NMR spectroscopy and molecular mechanics calculations carried out on the intermediate cycloadducts (+/-)-11 and (+/-)-12. Amino acid derivatives (+/-)-7 and (+/-)-8 were assayed at ionotropic and metabotropic glutamic acid receptor subtypes and their activity compared with that of trans-ACPD and cis-ACPD. The results show that the replacement of the omega-carboxylic group of the model compounds with the 3-hydroxy-delta2-isoxazoline moiety abolishes or reduces drastically the activity at the metabotropic glutamate receptors. Conversely, on passing from cis-ACPD to derivative (+/-)-8, the agonist activity at NMDA receptors is almost unaffected.
KW - Amino Acids
KW - Animals
KW - Binding, Competitive
KW - Cerebral Cortex
KW - Cyclization
KW - Cycloleucine
KW - Electrophysiology
KW - Excitatory Amino Acid Antagonists
KW - Glutamates
KW - Ligands
KW - Magnetic Resonance Spectroscopy
KW - Models, Molecular
KW - Molecular Conformation
KW - Rats
KW - Receptors, AMPA
KW - Receptors, Glutamate
KW - Receptors, Kainic Acid
KW - Receptors, Metabotropic Glutamate
KW - Receptors, N-Methyl-D-Aspartate
KW - Stereoisomerism
KW - gamma-Aminobutyric Acid
M3 - Journal article
C2 - 12484537
VL - 57
SP - 889
EP - 895
JO - Il Farmaco
JF - Il Farmaco
SN - 0014-827X
IS - 11
ER -
ID: 45613736